Not Signed In - Takeda Pharmaceutical To Release Sustained-Release Morphine Hydrochloride Capsule
Mon, 17 Apr 2006 06:00 AM EST
... Tokyo, April, 2006 (JCN) - Takeda Pharmaceutical has launched Passif, its proprietary sustained release capsule of morphine hydrochloride. Available in three dosages 30mg, 60mg and 120mg, the new agent is indicated for the treatment of pain control for cancer patients with moderate to severe pain... click link for more info. ...
Related Topics
- Valproic Acid Delayed or Extended-Release or Sprinkle Capsule
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Acetazolamide Sustained-Release
- Phentermine Sustained Release
- Niacin Extended Release
- Lovastatin Extended Release
- Didanosine Delayed Release Capsule
- Aspirin and Extended-Release Dipyridamole
- Duloxetine
- Morphine ER
- Metformin Extended-Release
- Pseudoephedrine Extended Release
- Dextroamphetamine Extended-Release
- Bupropion Sustained-Release (Zyban)
- Bupropion Extended-Release
- Chlorpromazine Extended-Release Capsules
- Zidovudine Capsule
- Mesalamine Oral
- Bupropion SR
- Verapamil Extended-release
email this page
print this page
bookmark this page
feedback on this page
